{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:54:33Z","timestamp":1781070873654,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["Grants-in-Aid for Scientific Research (C) (20K07923)"],"award-info":[{"award-number":["Grants-in-Aid for Scientific Research (C) (20K07923)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00415-021-10553-2","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T14:38:42Z","timestamp":1618497522000},"page":"4291-4295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High prevalence of serum anti-NH2-terminal of \u03b1-enolase antibodies in patients with multiple system atrophy and corticobasal syndrome"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-6347","authenticated-orcid":false,"given":"Akio","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Ezura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sugeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"10553_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jneuroim.2005.02.004","volume":"162","author":"A Fujii","year":"2005","unstructured":"Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, Suzuki H, Kuriyama M (2005) Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto\u2019s encephalopathy. J Neuroimmunol 162:130\u2013136","journal-title":"J Neuroimmunol"},{"key":"10553_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/jnnp.2006.093005","volume":"78","author":"H Nakagawa","year":"2007","unstructured":"Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M (2007) Hashimoto\u2019s encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 78:196\u2013197","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10553_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000342217","volume":"69","author":"A Matsunaga","year":"2013","unstructured":"Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M (2013) Hashimoto\u2019s encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol 69:14\u201320","journal-title":"Eur Neurol"},{"key":"10553_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","volume":"185","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M (2007) High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto\u2019s encephalopathy. J Neuroimmunol 185:195\u2013200","journal-title":"J Neuroimmunol"},{"key":"10553_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10072-011-0750-x","volume":"33","author":"K Inoue","year":"2012","unstructured":"Inoue K, Kitamura J, Yoneda M, Imamura E, Tokinobu H (2012) Hashimoto\u2019s encephalopathy presenting with micrographia as a typical feature of parkinsonism. Neurol Sci 33:395\u2013397","journal-title":"Neurol Sci"},{"key":"10553_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"10553_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51:745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10553_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp-2011-300875","volume":"83","author":"R Mathew","year":"2012","unstructured":"Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 83:405\u2013410","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10553_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139","journal-title":"Neurology"},{"key":"10553_CR10","doi-asserted-by":"publisher","first-page":"e6181","DOI":"10.1097\/MD.0000000000006181","volume":"96","author":"T Kishitani","year":"2017","unstructured":"Kishitani T, Matsunaga A, Ikawa M, Hayashi K, Yamamura O, Hamano T, Watanabe O, Tanaka K, Nakamoto Y, Yoneda M (2017) Limbic encephalitis associated with anti-NH2-terminal of alpha-enolase antibodies: a clinical subtype of Hashimoto encephalopathy. Medicine 96:e6181","journal-title":"Medicine"},{"key":"10553_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","volume":"76","author":"L Dahm","year":"2014","unstructured":"Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stocker W, Ehrenreich H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76:82\u201394","journal-title":"Ann Neurol"},{"key":"10553_CR12","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1212\/WNL.0000000000008785","volume":"94","author":"S Mattozzi","year":"2020","unstructured":"Mattozzi S, Sabater L, Escudero D, Arino H, Armangue T, Simabukuro M, Iizuka T, Hara M, Saiz A, Sotgiu S, Dalmau J, Graus F (2020) Hashimoto encephalopathy in the 21st century. Neurology 94:e217\u2013e224","journal-title":"Neurology"},{"key":"10553_CR13","unstructured":"Yoneda M, Matsunaga A, Ikawa M (2020) Reader response: Hashimoto encephalopathy in the 21st century. Neurology in press"},{"key":"10553_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nrl.2013.12.007","volume":"30","author":"MT Montojo","year":"2015","unstructured":"Montojo MT, Petit-Pedrol M, Graus F, Dalmau J (2015) Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. Neurologia 30:295\u2013301","journal-title":"Neurologia"},{"key":"10553_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0141-8130(91)90055-Y","volume":"13","author":"L Lebioda","year":"1991","unstructured":"Lebioda L, Stec B (1991) Mapping of isozymic differences in enolase. Int J Biol Macromol 13:97\u2013100","journal-title":"Int J Biol Macromol"},{"key":"10553_CR16","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1074\/jbc.275.8.5958","volume":"275","author":"A Subramanian","year":"2000","unstructured":"Subramanian A, Miller DM (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275:5958\u20135965","journal-title":"J Biol Chem"},{"key":"10553_CR17","doi-asserted-by":"publisher","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","volume":"287","author":"KS Kim","year":"2012","unstructured":"Kim KS, Choi YR, Park JY, Lee JH, Kim DK, Lee SJ, Paik SR, Jou I, Park SM (2012) Proteolytic cleavage of extracellular alpha-synuclein by plasmin: implications for Parkinson disease. J Biol Chem 287:24862\u201324872","journal-title":"J Biol Chem"},{"key":"10553_CR18","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1523\/JNEUROSCI.20-05-02003.2000","volume":"20","author":"Y Nakagami","year":"2000","unstructured":"Nakagami Y, Abe K, Nishiyama N, Matsuki N (2000) Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20:2003\u20132010","journal-title":"J Neurosci"},{"key":"10553_CR19","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1111\/j.1479-8301.2003.00029.x","volume":"4","author":"K Matsuda","year":"2004","unstructured":"Matsuda K (2004) Laminin and Alzheimer\u2019s disease. Psychogeriatrics 4:S19\u2013S38","journal-title":"Psychogeriatrics"},{"key":"10553_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1699-0463.1999.tb01529.x","volume":"107","author":"DB Rifkin","year":"1999","unstructured":"Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J (1999) Proteolytic control of growth factor availability. APMIS 107:80\u201385","journal-title":"APMIS"},{"key":"10553_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1160\/TH08-07-0427","volume":"100","author":"RD Balsara","year":"2008","unstructured":"Balsara RD, Ploplis VA (2008) Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb Haemost 100:1029\u20131036","journal-title":"Thromb Haemost"},{"key":"10553_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2377-12-131","volume":"12","author":"P Novak","year":"2012","unstructured":"Novak P, Williams A, Ravin P, Zurkiya O, Abduljalil A, Novak V (2012) Treatment of multiple system atrophy using intravenous immunoglobulin. BMC Neurol 12:131","journal-title":"BMC Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10553-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10553-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10553-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:39:31Z","timestamp":1633966771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10553-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10553"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10553-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}